SEARCH RESULT

Total Matching Records found : 3577

Son preference continues in India -Smriti Kak Ramachandran

-The Hindu Two out of five men in many States across the country believe that women should neither be seen nor heard. One in three men didn't allow their wives to wear clothes of their choice and 75 per cent expected their partners to agree to have sex. These findings are part of a study ‘Masculinity, Intimate Partner Violence and Son Preference in India' carried out in Uttar Pradesh, Madhya Pradesh, Rajasthan,...

More »

Wrong numbers: Attack on NREGA is misleading

-The Times of India Jagdish Bhagwati and Arvind Panagariya, hereafter BP, have argued for phasing out the National Rural Employment Guarantee Act in favour of cash transfers ("Rural Inefficiency Act", ToI, 23 October). It's surprising-and amusing-that two eminent economists have chosen to make a case based on prior beliefs and some sophomoric wordplay ('mis'leading economists), rather than on the available evidence. A survey by one of us of the empirical literature...

More »

Re-framing the MGNREGA debate -Yamini Aiyar

-The Hindu Reports that the National Democratic Alliance (NDA) government intends to radically restructure the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) have re-ignited public discussion on the scheme. Since its launch, debate on MGNREGA has been synonymous with ideological contestations on the role of the state and its welfare functions. Inevitably, the contours of the debate have been shrill, leaving little space for an evidence-based discussion on the...

More »

Time for another Green Revolution -Raju Barwale

-The Hindu Business Line Now that the gains from the first round have petered out, we need to embrace biotech to boost farm productivity As India seeks to ignite the next agrarian revolution, it must try and absorb some of the lessons of the Green Revolution. Currently, agricultural productivity and growth vary from State to State, resulting in regional disparities. Through targeted policymaking, investment in rural infrastructure and research, and ongoing support...

More »

New hepatitis drug to cost more in middle income nations; activists cry foul -Jyotsna Singh

-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close